Ajay Aggarwal: How NATCAN differs from other international audit programs and its future areas for development
Ajay Aggarwal, Clinical Director of National Cancer Audits, shared a post by National Cancer Audit Collaborating Centre (NATCAN) on LinkedIn:
“NATCAN is one of largest national cancer quality assurance and improvement programs in the world.
In our lancet oncology article below we profile the unique features of this audit program, how we differ from other programs internationally and future areas for development.
Congrats to all the ten cancer audit teams who are working very hard to improve the quality of cancer care in the NHS with our many partners and stakeholders.”
Quoting National Cancer Audit Collaborating Centre (NATCAN)‘s post:
“Read our Lancet Oncology paper.
‘NATCAN provides an opportunity to use data science to inform clinical quality improvement across a range of cancers and reduce unwarranted variation in care.'”
Authors: Ajay Aggarwal et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023